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Abstract
Background: Activin B has been reported to promote the proliferation and migration of keratinocytes in vitro via the RhoA-
JNK signaling pathway, whereas its in vivo role and mechanism in wound healing process has not yet been elucidated.
Principal Findings: In this study, we explored the potential mechanism by which activin B induces epithelial wound healing
in mice. Recombinant lentiviral plasmids, with RhoA (N19) and RhoA (L63) were used to infect wounded KM mice. The
wound healing process was monitored after different treatments. Activin B-induced cell proliferation on the wounded skin
was visualized by electron microscopy and analyzed by 59-bromodeoxyuridine (BrdU) incorporation assay. Protein
expression of p-JNK or p-cJun was determined by immunohistochemical staining and immunoblotting analysis. Activin B
efficiently stimulated the proliferation of keratinocytes and hair follicle cells at the wound area and promoted wound
closure. RhoA positively regulated activin B-induced wound healing by up-regulating the expression of p-JNK and p-cJun.
Moreover, suppression of RhoA activation delayed activin B-induced wound healing, while JNK inhibition recapitulated
phenotypes of RhoA inhibition on wound healing.
Conclusion: These results demonstrate that activin B promotes epithelial wound closure in vivo through the RhoA-Rock-
JNK-cJun signaling pathway, providing novel insight into the essential role of activin B in the therapy of wound repair.
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Introduction
Cutaneous wound repair is a complex process, which involves a
series of biological events involving inflammation, new tissue
formation and tissue remodeling [1]. During the process of new
tissue formation, the proliferation and migration of keratinocytes is
required for wound re-epithelialization and healing [2]. Various
growth factors and cytokines have been found to play a critical role
in wound healing [3]. Among these factors, activins, which are
members of the transforming growth factor b (TGF-b) superfam-
ily, play an important role in regulating normal function of
epithelial cells, skin development and wound healing [4,5]. Three
different forms of activin have been identified, including the
homodimers activin A (bAbA), activin B (bBbB) and the hetero-
dimer activin AB (bAbB) [6]. Strong and persistent induction of
activin B have been found in the hyperproliferative epithelia at the
wound edge and in the migrating epithelia of the tongue [4]. In
addition, overexpression of the activin antagonist follistatin or a
dominant-negative activin receptor IB mutant (dnActRIB) delayed
wound re-epithelialization after skin injury in mice [7,8], implying
a critical role of activin B in the regulation of wound healing.
Although the significance of activin B in wound closure has been
recognized, the mechanism by which activin B mediates wound re-
epithelialization and promotes wound healing after injury remains
poorly understood. Accumulating in vitro and in vivo evidence has
shown that mitogen-activated protein kinase kinase (MEK) kinase 1
(MEKK1)-driven c-Jun N-terminal kinase (JNK) activation contrib-
utes to activin-stimulated actin stress fiber formation, c-Jun
phosphorylation and cell migration [9,10,11]. Furthermore, acti-
vin-stimulated activation of MEKK1-JNK-cJun signal pathway
dependsonthe smallGproteinRhoAintheregulationofactinstress
fiber formation, actin cytoskeleton reorganization and subsequent in
vitrokeratinocytemigration[9].Nevertheless,theinvivoroleofactivin
B and the molecular mechanism by which activinB regulates wound
repair are still unclear.
In the present study, we investigated the effect of RhoA
activation on activin B-stimulated wound closure in KM mice by
using infection of the cells with dominant negative or constitutively
active RhoA expression constructs. The results showed that RhoA
positively mediated activin B-induced wound healing by induction
of JNK and cJun expression. Moreover, SP600125, a specific JNK
inhibitor, efficiently suppressed RhoA activation-mediated wound
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25143healing through an activin B mediated process, and the activin
antagonist-follistatin remarkably blocked activin B-induced wound
healing.
Results
Activin B promotes wound closure
After wound creation, mice were randomly assigned to two
groups; control and activin B group. Control group mice received
a 0.2 ml of PBS (pH 7.4) applied to the site surrounding the
wound three times a day. To induce wound healing, the same
volume of activin B (10 ng/ml) was administered to the wounded
skin. Compared with control, activin B promoted wound closure
(Fig. 1A). One day following treatment wound closure was
significantly higher with activin B treatment, and reached over
99% after 6 days (Fig. 1B). Hematoxylin and eosin (H&E) staining
indicated increased number of keratinocytes 3 or 5 days after
activin B treatment (Fig. 1C). Activin B administration promoted
re-epithelization and hair follicle regeneration after 6 days. SEM
analysis further confirmed newly formed epithelial tissue and
epithelial cells distributed along collagen on the surface of the
healed wound area after activin B treatment (Fig. 1D). Numerous
epithelial cells were found on the wound area cross-sections of
activin B-treated samples. Furthermore, reduced cell-cell contacts
and increased intercellular spaces were observed 5 days after
activin B treatment, as revealed by TEM analysis (Fig. 1E).
Figure 1. Time course of wound closure promoted by Activin B. Forty four mice were randomly assigned to PBS group and Act B group
(n=22). (A) Activin B promoted wound closure in KM mice as compared with control. KM mice received 0.2 ml of PBS or Activin B treatment three
times per day. The wound healing status was monitored every day. (B) The wound closure rate was calculated as described in Materials and Methods.
*P,0.01compared with PBS control. (C) H&E staining of the skin tissues surrounding wound sites. Scale bar: 100 mm. (D) SEM analysis showed that
activin B induced cell proliferation on the surface (black star) and cross-section (black arrows) of wound area. Re-epithelized squamous epitheliumi s
indicated by black arrowheads. (E) TEM analysis demonstrated that Activin B reduced cell-cell contacts and increased intercellular spaces (arrows)a t
wound area (b) compared with control (a). (c) The hair follicle seen in the regenerated skin after activin B treatment. Ea, Eb, Scale bar: 2 mm; Ec, Scale
bar: 5 mm.
doi:10.1371/journal.pone.0025143.g001
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could induce migration of mouse primary keratinocytes in vitro [9],
these data suggest that activin B has the ability to stimulate
migration of basal cells both in vitro and in vivo. Hair follicles also
emerged in the regenerated skin around the wound 5 days after
activin B treatment.
Activin B stimulates the proliferation of keratinocytes and
hair follicle cells
Next, we evaluated cell proliferation in wounded skin by BrdU
incorporation. The number of BrdU-positive cells increased
gradually and was comparable to control and activin B-treated
groups during first two days following wound introduction.
However, more BrdU-positive cells were observed in both epi-
thelium and hair follicles in activin B-treated mice on day 3 and 5
(Fig. 2), suggesting that activin B enhances the proliferation of
epithelial keratinocytes and hair follicle cells during the early stages
of wound healing.
Activin B-induced wound healing is regulated by RhoA
The small GTPase RhoA is essential in activin B-stimulated in
vitro keratinocyte migration [9]. To investigate the involvement of
RhoA signaling in activin B-induced in vivo wound healing,
wounded skin was infected with EGFP-tagged lentiviruses carrying
dominant negative RhoA (N19), constitutively active RhoA (L63)
or an empty (control) lentivirus. Three days after empty lentivirus,
RhoA N19 and RhoA L63 infection, green fluorescence was
detected in epithelial and dermal tissues by in vivo fluorescence
imaging (Fig. 3A, B, C). Fluorescent images obtained from fixed
tissue sections confirmed high viral infection efficiency in skin
tissues around the wound site, including the epidermal cell and
hair follicle (Fig. 3A9,B 9,C 9). Interestingly, lentiviral infection with
constitutively active RhoA (L63) remarkably enhanced wound
healing induced by activin B, while the dominant negative RhoA
(N19) infection delayed wound closure. The wound closure rate in
the control group was (47.3%66.5) and (76.1%64.0) on day 3
and day 5, respectively, whereas wound closure rate was
(77.2%62.8) on day 3 and (99.3%60.7) on day 5 in RhoAL63-
infected plus activin B group, (59.4%64.9) on day 3 and
(82.7%64.3) on day 5 in RhoAL63-infected alone group,
(52.0%65.0) on day 3 and (78.8%62.2) on day 5 in RhoAN19-
infected plus activin B group, and (44.9%66.7) on day 3 and
(72.1%65.9) on day 5 in RhoAN19-infected alone group.
Furthermore, we assessed the effect of Y27632, a specific inhibitor
of the RhoA effector Rock. Wounded skin was treated with 0.2 ml
of Y27632 (100 mM) instead of lentivirus prior to activin B
administration, or with Y27632 alone. As expected, blockade of
RhoA activity by Y27632 inhibited the Act B-accelerated wound
healing rate (Fig. 4A, B). In addition, no significant difference was
observed in the wound closure rate among empty lentiviral vector
infected, PBS-treated skin, RhoN19-infected plus activin B,
Y27632 plus activin B, RhoN19-infected and Y27632 alone
(Fig. 4A, B). These results demonstrated that RhoA-Rock signaling
positively regulated the wound closure induced by activin B. BrdU
incorporation experiments further illustrated that compared with
activin B group, activation of RhoA by RhoA L63-based lentivirus
infection drastically increased the proliferation of epithelium
keratinocytes on day 3 (Fig. 5A–C), and hair follicle cells on day
3 and 5 (Fig. 5B, C) during wound healing, whereas infection of
dominant negative RhoA (N19) reduced epithelium keratinocytes
and hair follicle cells proliferation both on day 3 and day 5
induced by activin B (Fig. 5). However there was no significant
Figure 2. Activin B enhanced the proliferation of keratinocytes and hair follicle cells in wounded skin. Twelve mice were randomly
assigned to PBS group and Act B group (n=6). (A) Immunohistochemistry was performed on the indicated day after PBS or activin B treatment. The
BrdU-positive cells were visualized on both epithelium (i) and hair follicle (ii), pictures were taken at 1006magnification, corresponding magnification
pictures i and ii were taken at 4006magnification, Scale bars: 100 mm. Data were quantified in three independent experiments and the number of
BrdU-positive cells per mm
2 in epithelium (B) and hair follicle (C) are presented. *P,0.05 compared with PBS control.
doi:10.1371/journal.pone.0025143.g002
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day 5 in PBS, RhoAN19 plus activin B and Y27632 plus activin B
(Fig. 5A, B) groups. In addition, no significant difference was
observed in the number of BrdU-positive cells between activin B
group and empty lentiviral vector infected plus activin B and
between Y27632 plus activin B and RhoAN19 plus activin B
(Fig. 5A–C). This suggests that RhoA signaling activation
contributes to the epithelium keratinocytes and hair follicle cell
proliferation, and therefore stimulated would healing induced by
activin B.
Activin B induces activation of JNK and cJun in wounded
skin
Three major mitogen-activated protein kinases (MAPKs), c-Jun
N-terminal kinase (JNK), extracellular signal-regulated kinase
(ERK) and p38, control a vast array of physiological processes
[12]. Among these MAPK family members, JNK is believed to be a
downstream mediator of RhoA-initiated signal transduction
pathway. Activation of JNK is required for activin B-induced actin
stress fiber formation, in vitro keratinocyte migration and wound
healing [9]. Compared with the PBS control, increased numbers of
p-JNK- and p-cJun-positive cells were found on the wounded skin
on day 3 and day 5 after activin B treatment, as revealed by
immunohistochemical analysis (Fig. 6A–D). Quantified immuno-
blot data revealed that after introduction of wound, the phosphor-
ylation of JNK in PBS group was decreased gradually. The levels of
JNK activation in Act B group were decreased initially; however,
they were increased rapidly from day 1, reaching the highest level
on day 3 followed by a gradual decrease. (Fig. 6E, F). Nevertheless,
the number of p-ERK- or p-p38-positive cells was not altered (data
not shown). Moreover, RhoA activation enhanced JNK activity in
the Activin B plus RhoAL63-treated group, while inactivation of
RhoA by dominant negative RhoAN19 decreased the activity of
JNK (Fig. 7A, B). The Rock inhibitor Y27632 had similar effects as
RhoAN19insuppressingJNKactivation(Fig.7A,B).Similarresults
were observed in p-cJun activation after different treatments
(Fig. 7C, D). These results together indicate that the JNK-cJun
signal pathway acts downstream of RhoA-Rock in activin B-
induced wound healing process.
JNK inhibition suppresses activin B-induced wound
closure
Since activation of JNK has been observed during wound
healing induced by activin B, we asked whether or not JNK
activation is required for wound closure. SP600125, which is a
specific inhibitor for JNK, was used for this purpose. As revealed
by immunohistochemisty staining, SP600125 significantly reduced
the level of p-JNK and p-cJun induced by activin B at wound site
(Fig. 8A–D), confirming that SP600125 efficiently blocks the JNK-
cJun signaling pathway. Importantly, JNK inhibition remarkably
suppressed the activin B induced-wound healing process (Fig. 8E,
F). The numbers of BrdU-positive cells in both epithelium and hair
follicle were dramatically decreased on day 3 and 5 after
SP600125 plus activin B and SP600125 alone treatment, as
compared with activin B administration alone (Fig. 8G–I). Thus
activation of the JNK-cJun pathway is necessary for activin B-
induced wound healing by promoting epithelium keratinocytes
and hair follicle cell proliferation.
RhoA mediates wound closure and cell proliferation
through JNK signaling after activin B treatment
To definitively determine the role of JNK in RhoA-mediated
wound healing, we investigated the effect of JNK inhibition by
SP600125 on RhoA activation (using RhoAL63 lentivirus in-
fection)-promoted wound healing after activin B treatment. On
day 3 and day 5 after activin B, RhoAL63 and SP600125
combination treatment, JNK inhibition suppressed wound healing
promoted by RhoAL63 and activin B (Fig. 9A, B), and reduced
numbers of BrdU-positive cells detected in epithelium and hair
follicles (Fig. 9C–E). These observations suggest that JNK is
Figure 3. Lentiviral infection of the wounded skin. Six mice were randomly assigned to EGF group, RhoAL63 group and RhoAN19 group (n=2).
After wound creation, 0.2 ml empty vectors (Plenti6/v5-EGFP), RhoAL63 and RhoAN19 with a titer of 1610
6 IU/ml were applied to the wound surface.
The green fluorescence was visualized by in vivo fluorescence imaging system three days after infection (A, B, C), dotted line mean wound. (A9,B 9,C 9)
The green fluorescence on fixed tissue sections was also observed under fluorescent microscope. HF, hair follicle; EP, epithelium; DE, dermis. White
arrow indicates epithelium and red arrow indicates the hair follicle. (A0,B 0,C 0) Sections were double stained with Hoechst 33258 to visualize the
nucleus. Scale bars: 100 mm.
doi:10.1371/journal.pone.0025143.g003
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proliferation after activin B treatment.
Follistatin suppresses activin B-induced wound healing
The biological activities of activins are regulated, usually inhibited,
by follistatin. Follistatin, an activin antagonist, regulates activin
activity by binding to activin and inhibiting its binding to receptor
[13,14]. Thus we asked whether follistatin could delay the wound
healing rate induced by activin B, and whether follistatin could
regulate the activity of downstream signaling JNK-cJun. Wounded
skin was treated with 0.2 ml of follistatin (10 ng/ml) prior to activin B
administration or with follistatin alone. As expected, follistatin
delayed the activin B-induced wound-healing rate (Fig. 10A, B).
Compared with the activin B group, decreased numbers of p-JNK-
and p-cJun-positive cells were found on the wounded skin on day 3
after activin B and follistatin treatment, or follistatin alone treatment,
as revealed by immunohistochemical analysis (Fig. 10C–F). These
data together indicate that the activation of the RhoA-JNK-cJun
pathway is necessary for activin B-induced wound healing.
Discussion
Wound repair is a complex process that can be roughly divided
into three continuous and overlapping phases: inflammatory
reaction, new tissue formation and tissue remodeling [1]. The
proliferation and migration of epithelial cells are key events for the
formation of epithelium [15,16]. During this process, keratinocytes
migrate to cover the wound surface and fill the wound space,
thereby contributing to wound re-epithelialization and healing [2].
Activin B, which is the homodimer subunit of activin, has been
recognized to stimulate the wound healing process [7,8]. However,
the molecular mechanism by which activin B mediates wound
closure is unclear.
In the present study, we investigated the underlying mechanism
by which activin B regulates the in vivo wound healing process. Our
results demonstrate that activin B increases the number of
epithelial cells at the wound edge. During migration, the cell
expands by making protrusions, such as large lamellipodia and
small filopodia, and contacts with the extracellular matrix (ECM).
The rear of the cell must detach from the substratum. Then, the
cell exerts a pulling force to translocate the cell body forward and
also retracts its rear by regulating actin and myosin [17,18]. As
revealed by TEM analysis, activin B significantly reduced cell-cell
contacts and increased intercellular spaces, and the cell rear was
detached from the substratum, suggesting that activin B has the
ability to stimulate cell migration.
The regeneration of hair follicles during wound repair shares a
common process with the hair follicle initiation during the
Figure 4. RhoA signal positively regulates the wound closure induced by activin B. Sixty five mice were randomly assigned to eight
groups: empty lentiviral vector (EGFP, n=10), constitutively active RhoA L63 (n=5), dominant negative RhoA N19 (n=5), Y27632 (n=5), Act B+EGFP
(n=10), Act B+RhoAL63 (n=10), Act B+RhoAN19 (n=10) and Act B+27632 (n=10). (A) As described in Materials and methods, animals were treated
with Act B+EGFP, Act B+RhoAL63, Act B+RhoAN19, Act B+Y27632 or alone empty lentiviral (EGFP), RhoAL63, RhoAN19 and Y27632 after wound
creation. Wound closure status in each group is presented. (B) Wound closure rate calculated on day 0, 3 and 5 after treatment. *P,0.05 compared
with PBS control.
doi:10.1371/journal.pone.0025143.g004
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the wound closure rate is closely correlated with scarring response
as well as hair follicle regeneration [21,22,23]. Most importantly,
the regeneration of hair follicles speeds wound closure and reduces
scar formation [24,25,26]. Here, newly formed hair buds were
observed on the basal epithelial tissues and an elevated number of
hair follicles were detected three days after activin B treatment
compared with the control group. The enhanced regeneration of
hair follicles was visible even after 42 days of activin B
administration (data not shown). Therefore, it can be concluded
that activin B stimulates wound healing by promoting cell
migration and hair follicle regeneration. Rho-family GTPases,
including RhoA, Cdc42 and Rac1, have recently emerged as
important regulators of cell polarity, protrusion and adhesion
during directional migration [18,27]. Activation of matrix
metalloproteinase-9 (MMP-9) occurres in response to keratinocyte
injury, which is dependent on two distinct pathways: (1) Rac1
and/or Cdc42-mediated activation of p38; (2) RhoA regulated
stimulation of JNK [28]. RhoA is required for efficient wound
closure of airway epithelial cells [29]. Constitutive activation of
RhoA has been found to regulate cytoskeletal reorganization
during intestinal epithelial cell spreading [30]. In the present study,
wounded skin tissues were successfully infected with RhoA-based
lentiviral vetors. Lentivirus infection with the constitutively active
RhoA (L63) sequence dramatically promoted the cell migration
towards the wound site and accelerated the wound healing process
induced by activin B, whereas the dominant negative RhoA (N19)
based infection delayed wound closure. These results are
consistent with previous reports showing that RhoA contributes
to activin-stimulated in vitro keratinocyte migration [9]. Collec-
tively, RhoA plays a critical role in mediating activin signals and
regulating both in vivo and in vitro keratinocyte migration.
Emerging evidencesuggests that JNK regulates cell migration and
its activation is important for wound repair [31,32,33]. Gazel et al.
Figure 5. Activation of RhoA contributes to the proliferation of epithelium keratinocytes and hair follicle cells during wound
healing. Twenty four mice were randomly assigned to four groups: Act B+EGFP (n=6), Act B+RhoAL63 (n=6), Act B+RhoAN19 (n=6) and Act
B+Y27632 (n=6). (A) Mice were treated with Act B+EGFP, Act B+RhoAL63, Act B+RhoAN19 or Act B+Y27632 after wound creation.
Immunohistochemistry was performed on the indicated day after treatment. BrdU-positive cells on epithelium (i) and hair follicle (ii), pictures
were taken at 1006magnification, and corresponding magnification pictures i and ii were taken at 4006magnification, Scale bars: 100 mm. Data
were quantified in three independent experiments and the number of BrdU-positive cells per mm
2 in epithelium (B) and hair follicle (C) is presented.
*P,0.05 compared with PBS control. **P,0.05 compared with PBS, Act B+RhoAN19 and Act B+Y27632 groups. ***P,0.05 compared with PBS, Act B,
Act B+EGFP, Act B+RhoAN19 and Act B+Y27632 groups.
doi:10.1371/journal.pone.0025143.g005
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differentiationofepidermalkeratinocytesandthusstimulatedwound
healing [34]. Our previous studies indicated that the phosphoryla-
tion of JNKinducesthe migration of keratinocytesand wound repair
in vitro [11]. Furthermore, activin B-stimulated keratinocyte
migration in vitro is tightly regulated by a RhoA-MEKK1-JNK
signaling pathway [9,10]. We found that enhanced activation of
JNK and cJun occurred during activin B-stimulated in vivo wound
closure. Blockade of JNK signaling by JNK-specific inhibitor greatly
suppressed cell proliferation at the wound site and subsequently
delayed wound closure. In addition, activation of RhoA by
constitutively active RhoA (L63) based lentiviral infection signifi-
cantly increased the phorsphorylation of JNK and cJun. In contrast,
dominant negative RhoA (N19) based lentiviral infection suppressed
theexpressionofphorsphorylatedJNKandcJun.Furthermore,JNK
inhibitor was sufficient to delay activin B-induced and RhoA-
mediated wound closure. Similarly, the activin antagonist-follistatin
remarkably blocked activin B-induced wound healing.
Figure 6. Activin B induced activation of JNK and cJun in wounded skin. Twelve mice were randomly assigned to PBS group and Act B
group (n=6). Immunohistochemistry indicated increased numbers of p-JNK-positive (A) and p-cJun-positive cells (C) at the wounded skin on day 3
and day 5 after activin B treatment, as compared with PBS control. Enlarged images of the boxed area were presented on the right side. Scale bars:
100 mm. Quantified percentages of p-JNK and p-cJun immunopositive cells are presented in (B) and (D) respectively. (E, F) Western blotting showed
the level of JNK phosphorylation reached the highest value on day 3 and higher than PBS group on day 1 to day 5. 3 h, 6 h, 12 h: 3, 6 and 12 hours
after wound. *P,0.05, **P,0.01, compared with PBS control.
doi:10.1371/journal.pone.0025143.g006
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epithelial wound healing through a RhoA-Rock-JNK-cJun
signaling pathway, which provides important rationale for wound
repair therapy. These results also offer some new approaches for
solving the problems of hair follicle regeneration during the wound
healing process.
Figure 7. JNK-cJun signaling pathway is involved in activin B-induced wound healing process. Twenty four mice were randomly
assigned to four groups: Act B+EGFP (n=6), Act B+RhoAL63 (n=6), Act B+RhoAN19 (n=6) and Act B+Y27632 (n=6). (A) Mice were treated with
empty lentivirus vector (Act B+EGFP), constitutively active RhoA (L63) (Act B+RhoAL63), dominant negative RhoA (N19) (Act B+RhoAN19) or Act
B+Y27632 after wound creation. Immunohistochemical staining for p-JNK (A) or p-cJun (C) was performed on indicated day after treatment. Pictures
were taken at 1006magnification, and corresponding magnification pictures were taken at 4006magnification, Scale bars: 100 mm. The percentage
of p-JNK-positive (B) or p-cJun-positive (D) cells was quantified. *P,0.05 compared with PBS control. **P,0.05 compared with PBS, Act B+RhoAN19,
and Act B+Y27632 groups. ***P,0.05 compared with PBS, Act B, Act B+EGFP, Act B+RhoAN19, and Act B+Y27632 groups.
doi:10.1371/journal.pone.0025143.g007
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Reagents
Activin B and Follistatin were purchased from R & D Systems
(Minneapolis, MN). Primary antibody for rabbit polyclonal p-JNK
was obtained from Promega (Madison, WI). Primary antibodies
for rabbit polyclonal p-cJun, p-ERK and p-p38 were purchased
from Cell Signaling Technology (Boston, MA). BrdU was
purchased from Sigma (St Louis, MO), and anti-BrdU antibody
was bought from Santa Cruz (Santa Cruz, CA). Goat anti-mouse
IgG/Biotin, goat anti-rabbit IgG/Biotin, avidin-biotin-peroxidase
complex and diaminobenzidine (DAB) were purchased from
Figure 8. JNK inhibition suppresses activin B-induced cell proliferation and wound closure. Twenty seven mice were randomly assigned
to two groups: Act B+SP600125 (n=16) and SP600125 (n=11). For JNK inhibition, 0.2 ml SP600125 (5 mM) applied to the wound surface 30 min prior
to 0.2 ml of activin B (10 ng/ml) administration, or SP600125 alone. Mice received SP600125 and activin B treatment three times a day.
Immunohistochemical staining for p-JNK and p-cJun showed that JNK inhibitor suppressed the expressions of phosphorylated (activated) JNK (A, B)
and cJun (C, D) after activin B administration. (E) SP600125 suppressed wound closure induced by activin B and delayed wound healing. (F) Wound
closure rate was calculated 3 and 5 days after treatment. (G) BrdU-positive cells were visualized on both epithelium (i) and hair follicle (ii). Pictures
were taken at 1006 magnification, and corresponding magnification pictures were taken at 4006 magnification. Scale bars: 100 mm. Data were
quantified in three independent experiments and the number of BrdU-positive cells per mm
2 in epithelium (H) and hair follicle (I) was presented.
*P,0.05 compared with PBS control. **P,0.05 compared with PBS, Act B+SP600125 and/or SP600125 groups.
doi:10.1371/journal.pone.0025143.g008
Activin B in Wound Healing
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Specific inhibitors for JNK (SP600125) and RhoA (Y27632) were
also obtained from Santa Cruz.
In vivo wound creation
A total of 247 male and female specific pathogen-free (SPF) level
Kunming (KM) mice with body mass of 20 to 25 g, were provided
by the Southern Medical University laboratory animal center
(SCXK 2006-0015). All experimental procedures were in
compliance with the National Institutes of Health guidelines for
Care and Use of Laboratory Animals and were approved by the
Bioethics Committee of Southern Medical University. For in vivo
wound creation, 10–12 weeks old mice were anesthetized with an
intraperitoneal injection of 10% chloral hydrate (w/v; 0.003 ml/g
body mass). Full-thickness skin wounds of 0.560.5 cm
2 were
created on each mouse on the dorsal-right or -left shaved skin with
sterile scissors as described previously [10]. Wounds were left
uncovered after injury, and wound areas were measured at various
Figure 9. JNK inhibitor efficiently suppresses RhoA activation-promoted wound closure after activin B treatment. Forty three mice
were randomly assigned to three groups: Act B+EFGP+SP600125 (n=16), Act B+RhoAL63+SP600125 (n=16) and RhoAL63+SP600125 (n=11). Mice
were infected with GFP or RhoAL63 after wound creation. Thirty minutes after lentivirus infection, 0.2 ml SP600125 (5 mM) was injected on the same
area. After another 30 min, 0.2 ml of activin B (10 ng/ml) was administered. Mice were received such SP600125 and activin B treatment three times a
day. (A) SP600125 suppressed wound closure in mice treated with activin B. (B) Wound closure rate was calculated 3 and 5 days after treatment. (C)
BrdU-positive cells were visualized on both epithelium (i) and hair follicle (ii). Pictures were taken at 1006 magnification, and corresponding
magnification pictures were taken at 4006 magnification. Scale bars: 100 mm. Data were quantified in three independent experiments and the
number of BrdU-positive cells per mm
2 in epithelium (D) and hair follicle (E) was presented. *P,0.05 compared with PBS control. **P,0.05 compared
with PBS, Act B+RhoAL63+SP600125, RhoAL63+SP600125 and Act B+EGFP+SP600125 groups, ***P,0.05 compared with PBS, Act B, Act
B+RhoAL63+SP600125, RhoAL63+SP600125 and Act B+EGFP+SP600125 groups.
doi:10.1371/journal.pone.0025143.g009
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using the following formula: Wound closure rate (%)=[(Original
wound area-Open area on final day)/Original wound area]6100.
Lentivirus infection
The lentiviruses bearing dominant-negative mutants RhoA
(RhoAN19) and gain of function mutants RhoA (RhoAL63) were
generated using general virology techniques, and were named Lenti-
RhoAN19 and Lenti-RhoAL63, respectively. All viral preparations
were tittered to contain 1610
6 infectious units/ml (data not shown).
After wound creation, 0.2 ml of viral vector with a titer of
1610
6 IU/ml was applied to the wound surface. The infection
efficiency was determined using an in vivo fluorescence imaging
system (lumazone 1024, Roper Scientific, USA) three days after
lentivirus infection. The green fluorescence of tissue sections was
observed using a fluorescent microscope (IX70, Olympus, Japan).
Histological examination and immunohistochemistry
Animals were anesthetized and the complete wound with
0.5 cm margins were carefully removed and fixed in 4%
paraformaldehyde (PFA), dehydrated with a graded ethanol series,
cleared in dimethylbenzene and embedded in paraffin. Five mm
sections were deparaffinized by immersing in dimethylbenzene
and then rehydrated. H&E staining was performed according to
standard procedures. Sections were then subjected to immuno-
histochemical analysis. Briefly, sections were heated in citrate
buffer (0.01 M, pH 6.0) for 5 min at 100uC and were then treated
with endogenous peroxidase (3% hydrogen peroxide solution) for
5 min at room temperature. After blocking in 10% goat serum for
another 30 min at room temperature, sections were immuno-
stained with primary antibodies for p-JNK (1:500), p-ERK (1:250),
p-p38 (1:800), p-cJun (1:100) or BrdU (1:50) diluted in phosphate
buffer solution (PBS) containing 0.1% Tween-20 and 5% bovine
serum albumin (BSA) overnight at 4uC. After washing three times
with PBST (PBS supplemented with 0.1% Tween-20), sections
were incubated with secondary antibodies, avidin-biotin-peroxi-
dase complex and DAB reagent. Subsequently, all sections were
double stained with hematoxylin and visualized under the
microscope (BX51, Olympus, Japan). Images were captured by
Image-pro plus software, and five-ten photomicrographs were
Figure 10. Follistatin efficiently suppresses RhoA activation-promoted wound closure after activin B treatment. Twenty six mice were
randomly assigned to two groups: Act B+Follistatin (n=13) and Follistatin (n=13). Mice were administered follistatin (0.2 ml 10 ng/ml), thirty minutes
after activin B (0.2 ml 10 ng/ml) was administrated, or not. (A) Follistatin suppressed wound closure in mice treated with activin B. (B) Wound closure
rate was calculated 3 and 5 days after treatment. Compared with Act B group, follistatin remarkably suppressed the Act B-induced wound healing
process. Immunohistochemical staining for p-JNK and p-cJun showed that follistatin suppressed the expression of phosphorylated (activated) JNK (C,
D) and cJun (E, F), compared with Act B group. Pictures were taken at 1006magnification, and corresponding magnification pictures were taken at
4006magnification. Scale bars: 100 mm. *P,0.05 compared with PBS control.
doi:10.1371/journal.pone.0025143.g010
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were estimated and presented as a percentage of the total number
of cells counted per area. All evaluations were carried out on
coded sections. The staining intensity was evaluated in the hair
follicle and in the different layers of epidermis [(stratum
granulosum, stratum spinosum (SS) and stratum basale (SB)] by
using Imageproplus (IPP). The area of interest (AOI) was selected
in the hair follicle and epidermis, where was yellow part and
showed protein expression. Then the different color in all images
was separated by Histogram Based Tool. During color separation,
the range of HIS (H means Tone, I means Color Saturation, S
means Intensity) respectively was H: 0–40 (p-JNK, p-cJun), H: 0–
50 (Brdu
+); S: 0–255; I: 0–255. Finally, we counted the number of
protein-positive cells and total cell number by blue hematoxylin
staining. The protein positivity (p-JNK and p-cJun)=protein-
positive cell number/total cell number6100%. The BrdU-positive
cells per mm
2=BrdU-positive cell number/the hair follicle or
epidermis area.
Electron microscopy analysis
Animals were anesthetized with intraperitoneal injection of 10%
chloral hydrate. The complete wounds with 0.5 cm margins were
carefully removed, and washed three times with PBS at 4uC. For
scanning electron microscopy (SEM), samples were then fixed with
2.5% glutaraldehyde for 2 days. After dehydration in an acetone
gradient [50% (v/v) acetone (10 min), 70% (v/v) acetone (15 min),
90% (v/v) acetone (15 min), 100% acetone (4615 min)], samples
were incubated with isoamyl acetate for 1 h. Spray dried samples
were analyzed using SEM (S-3000-N, Hitachi Science Systems,
Ltd, Japan). For preparation of transmission electron microscopy
(TEM) samples, animals were perfused with 4% PFA and 0.4%
glutaraldehyde under anesthesia. Tissues and full-thickness skin
from the wound sites (1 mm61m m 61 mm) were removed and
were post-fixed with osmic acid for 1 h. After dehydration in an
acetone gradient, samples were impregnated with a mixture of
acetone/resin (1:1, 1 h, room temperature; 1:2, 2 h, room
temperature) and incubated with resin at room temperature
overnight. Sections were stained and images were obtained under
an H-7500 TEM (Hitachi Science Systems, Ltd, Japan).
Western blot analysis
After wound, protein samples were extracted by following the
procedures essentially the same as described in detail elsewhere
[35]. The protein content was determined with BCA Protein Assay
Kit (Beyotime, Haimen, China) using bovine serum albumin as
standard. Protein sample (50 mg) was fractionated by SDS-PAGE
(10% polyacrylamide gels) and transferred to PVDF membrane
(Millipore, Bedford, MA). After blocking in 5% skim milk powder
for 2 hours at room temperature, the sample was incubated
overnight at 4uC with the Rabbit polyclonal anti-mouse primary
antibodies for p-JNK (Promega, Madison, WI), diluted 1:5000 in
TBS containing 5% BSA. After washing three times with TBST
(TBS supplemented with 0.1% Tween-20), the sample was
incubated 1 hour at room temperature with anti-rabbit HRP-
linked second antibodies. Bound antibodies were detected using
the chemiluminescent substrate ECL (Millipore, Bedford, MA).
Then washing with stripping buffer (Pierce protein, Thermo,
Rockford, IL) for 10 min at room temperature and blocking, the
sample was incubated overnight at 4uC with the Rabbit polyclonal
anti-mouse primary antibodies for JNK (Cell Signaling Technol-
ogy, Boston, MA), diluted 1:1000 in TBS containing 5% BSA, and
was incubated with second antibodies and detected. Western blot
bands were quantified using QuantityOne software by measuring
the band intensity (Area6OD) for each group and normalizing to
JNK as an internal control. The final results are expressed as fold
changes by normalizing the data to the control values.
Statistical analysis
Data were analyzed using SPSS 13.0 software and plotted as
mean 6 SD. Wound closure rate was evaluated by single factor
repeated measurement. Statistical significant differences were
carried out by one-way ANOVA.
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